Millennium Management
FLNA

Millennium Management’s Filana Therapeutics FLNA Stock Holding History

Millennium Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$621K – 7314
2021
Q3 		$621K Buy
10,000
+3,000
+43% +$250K ﹤0.01% 5151
2021
Q2 		$598K Buy
+7,000
New +$375K ﹤0.01% 5143

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Millennium Management's FLNA Position: Q1 2026 in Review

Millennium Management reduced its Filana Therapeutics (FLNA) stake by 74% in Q1 2026, selling an estimated $415K and leaving 72,588 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #5307.

Millennium Management first reported a position in FLNA in Q2 2013 and has held it in 23 quarters since. The position peaked at $10.3M in Q1 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Millennium Management held 72,588 shares of Filana Therapeutics worth $123K as of Q1 2026.
  • Millennium Management sold 201,811 Filana Therapeutics shares in Q1 2026, an estimated $415K.
  • Filana Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5307 holding.
  • Millennium Management first reported a position in Filana Therapeutics in Q2 2013 and has held it in 23 quarters since.
  • Millennium Management's Filana Therapeutics position peaked at $10.3M in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.